WittGen Biotechnologies
WittGen Bio leverages AI to analyze single-cell data, aiming to uncover new cancer therapeutic opportunities. Their platform, LEIBER-X, is designed to identify novel targets and biomarkers, monitor mechanism of action, and stratify patients by providing cellular-level resolution for drug discovery. The company's mission is to turn single-cell clarity into cancer therapeutic opportunities through AI, driving breakthroughs that conventional methods might miss.
WittGen Biotechnologies
WittGen Bio leverages AI to analyze single-cell data, aiming to uncover new cancer therapeutic opportunities. Their platform, LEIBER-X, is designed to identify novel targets and biomarkers, monitor mechanism of action, and stratify patients by providing cellular-level resolution for drug discovery. The company's mission is to turn single-cell clarity into cancer therapeutic opportunities through AI, driving breakthroughs that conventional methods might miss.